Allergan Shows Off Phase III Migraine Data Post author:Sam Post published:February 5, 2018 Post category:BioPharma The ACHIEVE I study included 1327 U.S. adult patients. Source: BioSpace You Might Also Like Reata Pharmaceuticals Updates Data Release Dates for Ongoing Phase II Trials February 27, 2018 GenKyoTex S.A. Provides Business Update For Q1 2017 April 26, 2017 Navidea Completes Sale Of North American Rights Of Lymphoseek To Cardinal Health March 5, 2017
